Prevalence and characteristics of hepatitis C virus coinfection in a human immunodefidency virus clinical trials group: The Terry Beirn Community Programs for Clinical Research on AIDS

Clinical Infectious Diseases

Volumn 36, Issue 10, 2003, Pages 1313-1317

  Tedaldi, Ellen M ^a,j   Huppler Hullsiek, Katherine ^b   Malvestutto, Carlos D ^c   Arduino, Roberto C ^d   Fisher, Evelyn J ^e   Gaglio, Paul J ^f   Jenny Avital, Elizabeth R ^g   McGowan, Joseph P ^h   Perez, George ⁱ  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^d UNIVERSITY OF TEXAS   (United States)

^e Richmond AIDS Consortium   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^g Harlem AIDS Treatment Group   (United States)

^h Bronx AIDS Research Consortium   (United States)

ⁱ NJ Community Research Initiative   (United States)

^j TEMPLE UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; AGED; ARTICLE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; PREVALENCE; PRIORITY JOURNAL; SUPERINFECTION;

ADULT; CD4 LYMPHOCYTE COUNT; CLINICAL TRIALS; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE;

EID: 0038750648     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/374841     Document Type: Article

References (26)

1. Geffray L, Rosenthal E, Cacoub P, et al. Mortality rate in HIV infected patients presenting with hepatitis C cirrhosis: results of the GERMIVC Multicenter survey conducted in French departments of internal medicine or infectious diseases. Rev Med Interne 1999; 20:1082-7.
2. Puoti M, Spinetti A, Ghezzi A, et al. Mortality from liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr 2000; 24:211-7.
3. Cacoub P, Geffray L, Rosenthal E, et al. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001; 32:1207-14.
4. Monga HK, Rodriguez-Barradas M, Breaux K, et al. Hepatitis C virus infection related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33:240-7.
5. Darby SC, Ewart D, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350(9089):1425-31.
6. Ragni MV, Bell S. Effect of human immunodeficiency virus infection on progression to end-stage liver disease in persons with hemophilia and hepatitis C virus infection. J Infect Dis 2001; 183:1112-5.
7. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C co-infected patients. Hepatology 1999; 30:1054-8.
8. Daar ES, Lynn H, Donfield S, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001; 183:589-95.
9. Soto B, Sancez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
10. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996; 23:1117-25.
11. Sulkowski M, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Heptatitis C and progression of HIV disease. JAMA 2002; 288:199-206.
12. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-7.
13. Alter MJ, Kruszon-Moran D, Nainan OV. The prevalence of hepatitis C infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62.
14. Staples CT Jr, Rimland D, Dudas D. Hepatitis C in the HIV Atlanta VA Cohort Study. Clin Infect Dis 1999; 29:150-4.
15. Garfein RS, Vlahhov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655-61.
16. Murrill CD, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infecfion among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002; 92:385-7.
17. Buchbinder SP, Katz M, Hessol NA, Liu J, O'Malley PM, Alter MJ. Hepatitis C virus infection in sexually active homosexual men. J Infect 1994; 29:263-9.
18. Thomas DL, Zenilman JM, Alter HJ, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768-75.
19. Rancinan C, Neau D, Saves M, et al. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? AIDS 2002; 16:1357-62.
20. Feldman JG, Minkhoff H, Landesman S, Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis 2000; 27:338-42.
21. Rooney G, Gilson RJ. Sexual transmission of hepatitis C virus infection. Sex Transm Infect 1999; 74:399-404.
22. Diaz T, Greenberg B, Cuevas Y, Garfein R. Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. J Womens Health Gend Based Med 2001; 10:371-80.
23. Neaigus A, Friedman SR, Des Jarlais DC. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Infect Dis 2001; 184:359-63.
24. Woody GE, VanEtten-Lee M, McKirnan D, et al. Substance use among men who have sex with men: comparison with a national household survey. J Acquir Immune Defic Syndr 2001; 27:86-90.
25. Remien RH, Rabkin JG, et al. Remission of substance use disorders: gay men in the first decade of AIDS. J Stud Alcohol 1995; 56:226-32.
26. Diaz T, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001; 91:23-30.